The MINICAP FLEX-PIERCING instrument offers flexibility for small size laboratories. The fully automated instrument meets the needs of the laboratory while providing clear-cut and precise separations utilizing capillary electrophoresis technology. This multi-parameter, compact, automated capillary electrophoresis instrument offers a comprehensive menu on serum and whole blood for Protein, Immunotyping, HbA1c, Hemoglobin and CDT (Carbohydrate Deficient Transferrin) testing.
For whole blood testing, the capped tubes are gently inverted to ensure adequate mixing of the samples providing accurate results. The instrument provides complete walk-away automation reducing overall labor requirements.
Sebia condensed its experience in a compact and fully featured instrument, with the same resolution as its CAPILLARYS instruments.
7 capillary electrophoresis techniques available on this compact platform.
Sample types: whole blood, serum
This compact bench instrument can process up to 28 samples in one go (26 on HbA1c, Hb and CDT), fully automated and allowing continuous loading.
Throughput (tests/hour)* System autonomy (minutes)
PROTEIN(E) 6 (serum) 20 84
IMMUNOTYPING (serum) 1.7 988
Hb A1c 7 240
HEMOGLOBIN(E) 7 240
CDT 10 168
* Using Software version 9.30
High throughput Serum Protein Electrophoresis, with high resolution results.
The high-resolution method for hemoglobin disorders screening.
The most reliable chronic alcohol abuse marker.
Fully automated monoclonal proteins identification by Capillarys electrophoresis.
Interview between Sebia and M. Jean Deenmamode, CDT IFCC Working Group Chair
Understand in 2 minutes how capillary electrophoresis works, and why it gives such high and clear resolution in lab testing.
IFCC Euromedlab 2021
Sebia booth: #121
Sebia Workshop: EduW22
IFCC Standardisation of the Sebia CDT measurement on CAPILLARYS 3 TERA.
IFCC Worldlab 2022
Sebia booth: #72
Sebia Workshop: EduW25
Educational Webinar with David G. Grenache, PhD, D(ABCC)
Chief Scientific Officer, TriCore Reference Laboratories
CDT is a sensitive and specific marker of chronic alcohol abuse, used in several contexts and notably including forensic settings, industries, clinical applications.
IFCC Euromedlab /WorldLab 2023
Sebia booth: #21
Sebia Workshop: EduW15
Educational Webinar with Dr Nadia Maria Porpiglia
Educational Webinar with Dr. Barbara De la Salle
IFCC CDT-Working Group standardized the CDT measurement.
Article from Jean Deenmamode, IFCC CDT working group chair in CLI magazine.
Hemoglobin C, D Punjab, E or S trait can interfere with hemoglobin A1c (HbA1c) results depending on the method of analysis used. Therefore, it is important to know the limitations of the method used for HbA1c determination.
The EurA1c trial, organized yearly, investigates the performance of HbA1c assays across countries and manufacturers.
This article assesses the performances of the different manufacturers and technologies (HPLC and CE) for Hb A2 measurement using both International Reference Reagent for HbA2 (WHO IRR 89/666) and analysis of three whole blood specimens over a range of HbA2, distributed to 56 laboratories located in 14 different countries.
This article reminds the reader of the importance of detecting the Hb variants when measuring HbA1c for the labs and clinicians to better interpret the results and to ensure optimal management of the diabetic patient.
This section contains information intended for wide distribution and may therefore contain product details or information that is not available or valid in your country.
Please contact your local Sebia representative. Information intended for healthcare professionals.
Carefully read the instructions in the reagent package inserts and instrument manuals.